Global burden and future trends of metabolic dysfunction-associated Steatotic liver disease: 1990-2021 to 2045

Abstract

MASLD poses a significant burden with notable gender and regional disparities. The projected increase by 2045 underscores the need for urgent public health interventions and targeted strategies to mitigate this growing epidemic.